Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)

Clinical trial NCT00288704 · COMPLETED

Trial details

NCT number: NCT00288704
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Familial Cold Autoinflammatory Syndrome (FCAS)Familial Cold Urticaria Muckle-Wells Syndrome (MWS)Genetic Diseases, Inborn

Start date: 2005-12-01
Primary completion: 2008-06-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.